JMVIX | JVMTX | JMVIX / JVMTX | |
Total Expense Ratio | 1.14 | 1.00 | 114% |
Annual Report Gross Expense Ratio | 1.14 | 1.11 | 103% |
Fund Existence | 16 years | 12 years | - |
Gain YTD | -2.827 | 3.456 | -82% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.89B | 21.8B | 9% |
Annual Yield % from dividends | 0.39 | 0.71 | 55% |
Returns for 1 year | -7.49 | -4.36 | 172% |
Returns for 3 years | 0.35 | 12.71 | 3% |
Returns for 5 years | 22.82 | 61.31 | 37% |
Returns for 10 years | -20.21 | 35.64 | -57% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XTJA | 27.94 | -0.37 | -1.29% |
Innovator US Equity Acclrtd Pls ETF Jan | |||
USSE | 30.82 | -0.60 | -1.91% |
Segall Bryant & Hamill Select Equity ETF | |||
CHI | 10.20 | -0.21 | -2.02% |
Calamos Convertible Opportunities and Income Fund | |||
EPRF | 17.32 | -0.36 | -2.04% |
Innovator S&P Investment Grade Prfrd ETF | |||
IBB | 121.69 | -2.98 | -2.39% |
iShares Biotechnology ETF |